CompuGroup Medical SE & Co. KGaA
CMPUYOTCHealthcare
$23.00
$-1.80(-7.26%)
Market Cap$1.2B
P/E Ratio—
52W High$27.33
52W Low$14.485
CompuGroup Medical SE & Co. KGaA (CMPUY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CMPUY · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2025Report Date: Apr 30, 2025EPS Actual
$0.23
Revenue
$0.31B
Fiscal Period
Q2 FY2025
FY ends December
Report Date
Apr 30, 2025
After Market Close
CMPUY reports quarterly as a OTC-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2026 | Apr 28, 2026 | — | — | — | — | — | — |
| ◌ Q1 FY2026 | Mar 4, 2026 | — | — | — | — | — | — |
| ◌ Q4 FY2025 | Nov 5, 2025 | — | — | — | — | — | — |
| ◌ Q3 FY2025 | Jul 31, 2025 | — | — | — | — | — | — |
| — Q2 FY2025 | Apr 30, 2025 | — | $0.23 | — | $0.31B | — | — |
| — Q1 FY2025 | Mar 6, 2025 | — | -$0.13 | — | $0.32B | — | — |
| — Q4 FY2024 | Nov 7, 2024 | — | $0.18 | — | $0.31B | — | — |
| — Q3 FY2024 | Jul 15, 2024 | — | $0.29 | — | $0.30B | — | — |
Q2 FY2026
Apr 28, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2026
Mar 4, 2026
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2025
Nov 5, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2025
Jul 31, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
Apr 30, 2025
EPS Actual
$0.23
EPS Est.
—
EPS Surpr.
—
Revenue
$0.31B
Q1 FY2025
Mar 6, 2025
EPS Actual
-$0.13
EPS Est.
—
EPS Surpr.
—
Revenue
$0.32B
Q4 FY2024
Nov 7, 2024
EPS Actual
$0.18
EPS Est.
—
EPS Surpr.
—
Revenue
$0.31B
Q3 FY2024
Jul 15, 2024
EPS Actual
$0.29
EPS Est.
—
EPS Surpr.
—
Revenue
$0.30B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q4 FY2024 | $0.00 | $0.00 | $0.00 | 0 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q1 FY2025 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2024 | $0.3B | $0.3B | $0.3B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q2 FY2025 | Apr 30, 2025 | — | $23.75 | $23.75 | +0.00% |
| — Q1 FY2025 | Mar 6, 2025 | — | $23.75 | $23.75 | +0.00% |
| — Q4 FY2024 | Nov 7, 2024 | — | $14.48 | $14.48 | +0.00% |
| — Q3 FY2024 | Jul 15, 2024 | — | $17.90 | $17.40 | -2.79% |
| — Q2 FY2024 | May 8, 2024 | — | $32.38 | $32.38 | +0.00% |
| — Q1 FY2024 | Mar 28, 2024 | — | $31.05 | $31.05 | +0.00% |
| — Q1 FY2024 | Feb 7, 2024 | — | $42.80 | $42.80 | +0.00% |
| — Q3 FY2023 | Sep 7, 2023 | — | $56.00 | $56.00 | +0.00% |
Q2 FY2025+0.00%
Report Date
Apr 30, 2025
EPS Beat/Miss
—
Price Before
$23.75
Price After
$23.75
Q1 FY2025+0.00%
Report Date
Mar 6, 2025
EPS Beat/Miss
—
Price Before
$23.75
Price After
$23.75
Q4 FY2024+0.00%
Report Date
Nov 7, 2024
EPS Beat/Miss
—
Price Before
$14.48
Price After
$14.48
Q3 FY2024-2.79%
Report Date
Jul 15, 2024
EPS Beat/Miss
—
Price Before
$17.90
Price After
$17.40
Q2 FY2024+0.00%
Report Date
May 8, 2024
EPS Beat/Miss
—
Price Before
$32.38
Price After
$32.38
Q1 FY2024+0.00%
Report Date
Mar 28, 2024
EPS Beat/Miss
—
Price Before
$31.05
Price After
$31.05
Q1 FY2024+0.00%
Report Date
Feb 7, 2024
EPS Beat/Miss
—
Price Before
$42.80
Price After
$42.80
Q3 FY2023+0.00%
Report Date
Sep 7, 2023
EPS Beat/Miss
—
Price Before
$56.00
Price After
$56.00
Beat Rate0 / 8 quarters
Largest Move-2.79% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CMPUY ends December
CompuGroup Medical SE & Co. KGaA (CMPUY) most recently reported earnings on April 30, 2025 for Q2 FY2025, posting EPS of $0.23 (in line with the analyst consensus of —). The next CMPUY earnings date is expected around September 1, 2026.
Each quarter, investors track CMPUY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CMPUY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CMPUY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CMPUY earnings · 4 questionsCompuGroup Medical SE & Co. KGaA's next earnings report is expected around September 1, 2026. CMPUY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CMPUY historically reports after market close (AMC).
CMPUY earnings datewhen is CMPUY earningsCMPUY next earnings datewhen does CMPUY report earningsCMPUY earnings calendar
▸ Source: FMP · CompuGroup Medical SE & Co. KGaA SEC filings · US GAAP · CompuGroup Medical SE & Co. KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026